STATCenter·
STAT+: Revolution Medicines’ pancreatic cancer drug has stunning commercial debut
Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.
Read at STAT →
Health · 1 sources covering this
STAT+: Revolution Medicines’ pancreatic cancer drug has stunning commercial debut
Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/185759cb289422b97a8bf2254aa1e8895ff8d32e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Revolution Medicines’ pancreatic cancer drug has stunning commercial debut"></iframe>
